ClinicalTrials.Veeva

Menu

Multimodal GA for Lumbar Spine Surgery

National Taiwan University logo

National Taiwan University

Status

Completed

Conditions

Lumbar Spine Fusion Surgery

Treatments

Drug: dexmedetomidine, ketamine co-administration with sevoflurane for general anesthesia
Drug: Conventional general anesthesia by administration of sevoflurane alone

Study type

Interventional

Funder types

Other

Identifiers

NCT05247177
202112040MIND

Details and patient eligibility

About

To evaluate the effects of multimodal general anesthesia on the recovery profile of elder patients undergoing lumbar spine fusion surgery.

Full description

Multimodal general anesthesia has been proposed in recent years. By administration of multiple agents acting on a different component of the nociceptive pathways, the multimodal general anesthesia may elicit maximal anesthetic effects with minimal anesthetic dose. These may be beneficial to improve postoperative recovery and reduce adverse effects such as postoperative delirium and perioperative neurocognitive impairment. It is not uncommon that elder patients undergoing lumbar spine fusion surgery suffer from postoperative poor recovery, postoperative delirium as well as the postoperative neurocognitive disorder. Therefore, this study aims to explore the potential effects of multimodal general anesthesia, which comprised with electroencephalography density spectrum array guided co-administration of sevoflurane, ketamine and dexmedetomidine, on the postoperative recovery profiles for elder patients undergoing lumbar spine fusion surgery.

Enrollment

100 patients

Sex

All

Ages

60 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

1. patients with ages at least 60-year undergoing elective lumbar spine surgery

Exclusion:

  1. A history of dementia
  2. Impaired liver function, eg. AST or ALT >100; liver cirrhosis > Child B class
  3. Impaired renal function, cGFR< 60 ml/min/1.73 m2
  4. Cardiac dysfunction, such as heart failure > NYHA class II

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

100 participants in 2 patient groups

Multimodal general anesthesia
Experimental group
Description:
General anesthesia maintained by co-administration of sevoflurane, dexmedetomidine and ketamine by using a predefined EEG density spectrum array pattern
Treatment:
Drug: dexmedetomidine, ketamine co-administration with sevoflurane for general anesthesia
Conventional general anesthesia
Active Comparator group
Description:
General anesthesia maintained by administration of sevoflurane alone to keep a bispectral index between 40-60
Treatment:
Drug: Conventional general anesthesia by administration of sevoflurane alone

Trial contacts and locations

1

Loading...

Central trial contact

Chun-Yu Wu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems